glp-1 antibody Engineering of a analogue peptide/anti-PCSK9 fusion for type 2 diabetes treatment Cited in 1 publication Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23





























